The company's drug discovery platforms, NerveSim and BrainSim, focus on preclinical pharmaceutical development and therapeutic development, providing an alternative to costly animal testing and ineffective 2D models. AxoSim's technology empowers advancements in human neuroscience and accelerates the drug development process by mimicking the in vivo nervous system in an in vitro setting. As a contract research organization, AxoSim helps pharmaceutical companies develop drugs faster, ultimately benefiting patients. To learn more about AxoSim's services, email [email protected].